These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

338 related items for PubMed ID: 20675931

  • 1. [Genetic basis for skeletal disease. Establishment of novel treatments for fibrodysplasia ossificans progressiva (FOP)].
    Katagiri T.
    Clin Calcium; 2010 Aug; 20(8):1204-11. PubMed ID: 20675931
    [Abstract] [Full Text] [Related]

  • 2. [Cytokines in bone diseases. BMP signaling and fibrodysplasia ossificans progressiva].
    Katagiri T, Kamizono J, Nakashima Y, Kitoh H, Susami T, Haga N.
    Clin Calcium; 2010 Oct; 20(10):1510-7. PubMed ID: 20890033
    [Abstract] [Full Text] [Related]

  • 3. ALK2 R206H mutation linked to fibrodysplasia ossificans progressiva confers constitutive activity to the BMP type I receptor and sensitizes mesenchymal cells to BMP-induced osteoblast differentiation and bone formation.
    van Dinther M, Visser N, de Gorter DJ, Doorn J, Goumans MJ, de Boer J, ten Dijke P.
    J Bone Miner Res; 2010 Jun; 25(6):1208-15. PubMed ID: 19929436
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Establishment of a novel model of chondrogenesis using murine embryonic stem cells carrying fibrodysplasia ossificans progressiva-associated mutant ALK2.
    Fujimoto M, Ohte S, Shin M, Yoneyama K, Osawa K, Miyamoto A, Tsukamoto S, Mizuta T, Kokabu S, Machiya A, Okuda A, Suda N, Katagiri T.
    Biochem Biophys Res Commun; 2014 Dec 12; 455(3-4):347-52. PubMed ID: 25446088
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genetic abnormalities in fibrodysplasia ossificans progressiva.
    Miao J, Zhang C, Wu S, Peng Z, Tania M.
    Genes Genet Syst; 2012 Dec 12; 87(4):213-9. PubMed ID: 23229308
    [Abstract] [Full Text] [Related]

  • 15. Investigations of activated ACVR1/ALK2, a bone morphogenetic protein type I receptor, that causes fibrodysplasia ossificans progressiva.
    Kaplan FS, Seemann P, Haupt J, Xu M, Lounev VY, Mullins M, Shore EM.
    Methods Enzymol; 2010 Dec 12; 484():357-73. PubMed ID: 21036241
    [Abstract] [Full Text] [Related]

  • 16. Role of altered signal transduction in heterotopic ossification and fibrodysplasia ossificans progressiva.
    Shore EM, Kaplan FS.
    Curr Osteoporos Rep; 2011 Jun 12; 9(2):83-8. PubMed ID: 21340697
    [Abstract] [Full Text] [Related]

  • 17. Palovarotene Inhibits Heterotopic Ossification and Maintains Limb Mobility and Growth in Mice With the Human ACVR1(R206H) Fibrodysplasia Ossificans Progressiva (FOP) Mutation.
    Chakkalakal SA, Uchibe K, Convente MR, Zhang D, Economides AN, Kaplan FS, Pacifici M, Iwamoto M, Shore EM.
    J Bone Miner Res; 2016 Sep 12; 31(9):1666-75. PubMed ID: 26896819
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Deregulated bone morphogenetic protein receptor signaling underlies fibrodysplasia ossificans progressiva.
    de Gorter DJ, Jankipersadsing V, Ten Dijke P.
    Curr Pharm Des; 2012 Sep 12; 18(27):4087-92. PubMed ID: 22630080
    [Abstract] [Full Text] [Related]

  • 20. Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.
    Kaplan FS, Xu M, Seemann P, Connor JM, Glaser DL, Carroll L, Delai P, Fastnacht-Urban E, Forman SJ, Gillessen-Kaesbach G, Hoover-Fong J, Köster B, Pauli RM, Reardon W, Zaidi SA, Zasloff M, Morhart R, Mundlos S, Groppe J, Shore EM.
    Hum Mutat; 2009 Mar 12; 30(3):379-90. PubMed ID: 19085907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.